Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Tuberculosis trials, already struggling, hit hard by US sequester

Nature Medicine volume 19, pages 798–799 (2013)Cite this article

Subjects

A Correction to this article was published on 06 August 2013

This article has been updated

The US federal spending cuts imposed by the so-called sequester have made a brutal dent in research spending: the country's National Institutes of Health (NIH) and National Science Foundation are among the agencies that must shed roughly 5% of their budgets this year. That's bad news for research on global killers such as cancer and HIV/AIDS, but the prospects are perhaps even bleaker for fields that are already underfunded, such as research into tuberculosis.

According to the New York–based advocacy organization Treatment Action Group, tuberculosis research received $209 million from the NIH in 2011—a small sum, critics complain, compared with the $3.1 billion the agency invested in HIV/AIDS research. That same year, the tuberculosis pandemic was responsible for 1.4 million deaths, almost as many as attributed to HIV/AIDS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 29 July 2013

     In the July 2013 issue, the article entitled “Tuberculosis trials, already struggling, hit hard by US sequester” (Nat. Med. 19, 798–799, 2013) incorrectly referred to the information source behind an expected funding decline for the Parasitic Diseases and Malaria program at the CDC Center for Global Health as the US National Institute of Allergy and Infectious Diseases. In fact, the source was the Global Health Technologies Coalition. The error has been corrected in the HTML and PDF versions of the article.

Authors
  1. Trevor Quirk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quirk, T. Tuberculosis trials, already struggling, hit hard by US sequester. Nat Med 19, 798–799 (2013). https://doi.org/10.1038/nm0713-798b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0713-798b

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing